Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Abstract #4132: Depletion of radio-resistatnt regulatory T cells enhances anti-tumor immunity during homeostatic proliferation

Junko Baba, Satoshi Watanabe, Takao Miyabayashi, Hiroshi Kagamu, Hiroshi Tanaka, Katsuya Deguchi, Chunrui Tan, Suyu Shu, Hirohisa Yoshizawa, Fumitake Gejyo

Cancer Res (2009) 69 (9_Supplement): 4132.

Published: 01 May 2009

View articletitled, Abstract #4132: Depletion of radio-resistatnt regulatory T cells enhances anti-tumor immunity during homeostatic proliferation

Journal Articles

Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12

Rongxiu Zheng, Peter A. Cohen, Christopher A. Paustian, Terrence D. Johnson, Walter T. Lee, Suyu Shu, Gary K. Koski

Cancer Res (2008) 68 (11): 4045–4049.

https://doi.org/10.1158/0008-5472.CAN-07-6669

Published: 02 June 2008

View articletitled, Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12

Journal Articles

Myeloid-derived suppressor cells from tumor-bearing animals inhibit antitumor T cell response in the tumor-draining lymph-node

Satoshi Watanabe, Katsuya Deguchi, Rongxiu Zheng, Lixin Wang, Peter Cohen, Suyu Shu

Cancer Res (2008) 68 (9_Supplement): 254.

Published: 01 May 2008

View articletitled, Myeloid-derived suppressor cells from tumor-bearing animals inhibit antitumor T cell response in the tumor-draining lymph-node

Journal Articles

Role of sentinel lymph node harboring 4T1 tumor metastases in the development of systemic antitumor immune response

Katsuya Deguchi, Satoshi Watanabe, Terrence Johnson, Suyu Shu

Cancer Res (2008) 68 (9_Supplement): 1038.

Published: 01 May 2008

View articletitled, Role of sentinel lymph node harboring 4T1 tumor metastases in the development of systemic antitumor immune response

Journal Articles

Tumor-infiltrating lymphocytes (TIL) contain a subset of suppressor CD8⁺ T cells which can inhibit primary sensitization of tumor-specific effector T cells

Li-Xin Wang, Suyu Shu, Gregory Plautz

Cancer Res (2008) 68 (9_Supplement): 4634.

Published: 01 May 2008

View articletitled, Tumor-infiltrating lymphocytes (TIL) contain a subset of suppressor CD8+ T cells which can inhibit primary sensitization of tumor-specific effector T cells

Journal Articles

Tumor-induced CD11b⁺Gr-1⁺ myeloid cells promote tumor growth and regulate T cell sensitization in the draining lymph node

Satoshi Watanabe, Rongxiu Zheng, Katsuya Deguchi, Li-Xin Wang, Peter Cohen, Suyu Shu

Cancer Res (2007) 67 (9_Supplement): 218.

Published: 01 May 2007

View articletitled, Tumor-induced CD11b+Gr-1+ myeloid cells promote tumor growth and regulate T cell sensitization in the draining lymph node

Journal Articles

Tumor-infiltrating lymphocytes (TIL) contain effector and regulatory subsets that can be effectively segregated and hyperexpanded in vitro with maintenance of distinct functional properties.

Li-Xin Wang, Suyu Shu, Gregory Plautz

Cancer Res (2007) 67 (9_Supplement): 964.

Published: 01 May 2007

View articletitled, Tumor-infiltrating lymphocytes (TIL) contain effector and regulatory subsets that can be effectively segregated and hyperexpanded in vitro with maintenance of distinct functional properties.

Journal Articles

Generation of therapeutic T cells from lymph nodes of mice stimulated with dendritic-tumor fusion hybrids followed by in vitro anti-CD3/IL-2 activation

Rongxiu Zheng, Peter Cohen, Suyu Shu

Cancer Res (2007) 67 (9_Supplement): 2730.

Published: 01 May 2007

View articletitled, Generation of therapeutic T cells from lymph nodes of mice stimulated with dendritic-tumor fusion hybrids followed by in vitro anti-CD3/IL-2 activation

Journal Articles

Synergistic effects of dendritic-tumor fusion vaccine and adoptive immunotherapy for the treatment of spontaneous metastases of the 4T1 mammary adenocarcinoma in mice

Hidemasa Tamai, Jorgen Kjaergaard, Hideyuki Kuriyama, Suyu Shu

Cancer Res (2006) 66 (8_Supplement): 743.

Published: 15 April 2006

View articletitled, Synergistic effects of dendritic-tumor fusion vaccine and adoptive immunotherapy for the treatment of spontaneous metastases of the 4T1 mammary adenocarcinoma in mice

Journal Articles

CD4 tumor-reactive T cells enhance intratumoral proliferation and effector function of CD8 cells and synergistically mediate tumor regression.

Li-Xin Wang, Suyu Shu, Gregory E. Plautz

Cancer Res (2006) 66 (8_Supplement): 1308–1309.

Published: 15 April 2006

View articletitled, CD4 tumor-reactive T cells enhance intratumoral proliferation and effector function of CD8 cells and synergistically mediate tumor regression.

Journal Articles

Toll-like receptor agonists provide a third signal function for dendritic-tumor fusion immunotherapy of murine tumors

Rongxiu Zheng, Gary Koski, Hideyuki Kuriyama, Peter A. Cohen, Suyu Shu

Cancer Res (2006) 66 (8_Supplement): 741.

Published: 15 April 2006

View articletitled, Toll-like receptor agonists provide a third signal function for dendritic-tumor fusion immunotherapy of murine tumors

Journal Articles

Host Lymphodepletion Augments T Cell Adoptive Immunotherapy through Enhanced Intratumoral Proliferation of Effector Cells

Li-Xin Wang, Suyu Shu, Gregory E. Plautz

Cancer Res (2005) 65 (20): 9547–9554.

https://doi.org/10.1158/0008-5472.CAN-05-1175

Published: 17 October 2005

View articletitled, Host Lymphodepletion Augments T Cell Adoptive Immunotherapy through Enhanced Intratumoral Proliferation of Effector Cells

Journal Articles

Distinct operative mechanisms of OX-40R ligation and IL-12 in generation of therapeutic antitumor responses initiated by DC-tumor fusion cell vaccination

Hideyuki Kuriyama, Jorgen Kjaergaard, Hidemasa Tamai, Hong-Ming Hu, Andrew D. Weinberg, Suyu Shu

Cancer Res (2005) 65 (9_Supplement): 999.

Published: 01 May 2005

View articletitled, Distinct operative mechanisms of OX-40R ligation and IL-12 in generation of therapeutic antitumor responses initiated by DC-tumor fusion cell vaccination

Journal Articles

Active immunization of advanced tumors with DC-tumor electrofusion hybrids and OX40R mAb is rendered successful by remote, nonmyeloablative irradiation or by transfer of irradiated bone marrow cells

Jorgen Kjaergaard, Mohamed Awad, Richard W. Childs, John F. Tisdale, Suyu Shu, Peter A. Cohen

Cancer Res (2005) 65 (9_Supplement): 998.

Published: 01 May 2005

View articletitled, Active immunization of advanced tumors with DC-tumor electrofusion hybrids and OX40R mAb is rendered successful by remote, nonmyeloablative irradiation or by transfer of irradiated bone marrow cells

Journal Articles

Preliminary hyperexpansion of mouse CD34^pos stem cells provides multipotent dendritic cell (DC) precursors for tumor-DC hybridization and active immunization

Mohamed Awad, Jorgen Kjaergaard, Hideyuki Kuriyama, Christopher A. Distel, John F. Tisdale, Gary K. Koski, Suyu Shu, Peter A. Cohen

Cancer Res (2005) 65 (9_Supplement): 811.

Published: 01 May 2005

View articletitled, Preliminary hyperexpansion of mouse CD34pos stem cells provides multipotent dendritic cell (DC) precursors for tumor-DC hybridization and active immunization

Journal Articles

Ex vivo potentiation of anti-tumor T-cell therapeutic efficacy reflects early enhancements in trafficking, decreased apoptotic susceptibility, and diminished granzyme/perforin expression

Mohamed Awad, Jorgen Kjaergaard, Christopher A. Distel, Danielle Kish, Judith A. Drazba, Gary K. Koski, Brian J. Czerniecki, Robert L. Fairchild, James H. Finke, Suyu Shu, Peter A. Cohen

Cancer Res (2005) 65 (9_Supplement): 1004–1005.

Published: 01 May 2005

View articletitled, Ex vivo potentiation of anti-tumor T-cell therapeutic efficacy reflects early enhancements in trafficking, decreased apoptotic susceptibility, and diminished granzyme/perforin expression

Journal Articles

Active immunotherapy of advanced intracranial tumors through intrasplenic vaccination with DC-tumor electrofusion heterokaryons

Jorgen Kjaergaard, Gregory Plautz, Li-Xin Wang, Hideyuki Kuriyama, Keiji Shimizu, David Weng, Suyu Shu

Cancer Res (2004) 64 (7_Supplement): 294.

Published: 01 April 2004

View articletitled, Active immunotherapy of advanced intracranial tumors through intrasplenic vaccination with DC-tumor electrofusion heterokaryons

Journal Articles

Nonmyeloablative radiation enables successful anti-tumor adoptive immunotherapy by an abscopal (remote) mechanism associated with activation and mobilization of CD34(pos) stem cells.

Peter A. Cohen, Liaomin Peng, Mohamed Awad, Jorgen Kjaergaard, Richard W. Childs, John F. Tisdale, Gregory E. Plautz, Suyu Shu

Cancer Res (2004) 64 (7_Supplement): 572–573.

Published: 01 April 2004

View articletitled, Nonmyeloablative radiation enables successful anti-tumor adoptive immunotherapy by an abscopal (remote) mechanism associated with activation and mobilization of CD34(pos) stem cells.

Journal Articles

Adoptive immunotherapy with polyclonal tumor-reactive CD8 T cells hyperexpanded to greater than 10⁸-fold.

Gregory E. Plautz, Li-Xin Wang, Suyu Shu

Cancer Res (2004) 64 (7_Supplement): 501.

Published: 01 April 2004

View articletitled, Adoptive immunotherapy with polyclonal tumor-reactive CD8 T cells hyperexpanded to greater than 108-fold.

Journal Articles

In vitro correlates of anti-tumor T cell adoptive therapy: Culture conditions can dictate therapeutic outcome and T cell apoptotic susceptibility independent of detectable repertoire shifts

Mohamed S. Awad, Liaomin Peng, Jorgen Kjaergaard, Lee M. Akst, Judith A. Drazba, Gary K. Koski, Brian J. Czerniecki, Gregory E. Plautz, James H. Finke, Suyu Shu, Peter A. Cohen

Cancer Res (2004) 64 (7_Supplement): 1084.

Published: 01 April 2004

View articletitled, In vitro correlates of anti-tumor T cell adoptive therapy: Culture conditions can dictate therapeutic outcome and T cell apoptotic susceptibility independent of detectable repertoire shifts

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract #4132: Depletion of radio-resistatnt regulatory T cells enhances anti-tumor immunity during homeostatic proliferation

Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12

Myeloid-derived suppressor cells from tumor-bearing animals inhibit antitumor T cell response in the tumor-draining lymph-node

Role of sentinel lymph node harboring 4T1 tumor metastases in the development of systemic antitumor immune response

Tumor-infiltrating lymphocytes (TIL) contain a subset of suppressor CD8⁺ T cells which can inhibit primary sensitization of tumor-specific effector T cells

Tumor-induced CD11b⁺Gr-1⁺ myeloid cells promote tumor growth and regulate T cell sensitization in the draining lymph node

Tumor-infiltrating lymphocytes (TIL) contain effector and regulatory subsets that can be effectively segregated and hyperexpanded in vitro with maintenance of distinct functional properties.

Generation of therapeutic T cells from lymph nodes of mice stimulated with dendritic-tumor fusion hybrids followed by in vitro anti-CD3/IL-2 activation

Synergistic effects of dendritic-tumor fusion vaccine and adoptive immunotherapy for the treatment of spontaneous metastases of the 4T1 mammary adenocarcinoma in mice

CD4 tumor-reactive T cells enhance intratumoral proliferation and effector function of CD8 cells and synergistically mediate tumor regression.

Toll-like receptor agonists provide a third signal function for dendritic-tumor fusion immunotherapy of murine tumors

Host Lymphodepletion Augments T Cell Adoptive Immunotherapy through Enhanced Intratumoral Proliferation of Effector Cells

Distinct operative mechanisms of OX-40R ligation and IL-12 in generation of therapeutic antitumor responses initiated by DC-tumor fusion cell vaccination

Active immunization of advanced tumors with DC-tumor electrofusion hybrids and OX40R mAb is rendered successful by remote, nonmyeloablative irradiation or by transfer of irradiated bone marrow cells

Preliminary hyperexpansion of mouse CD34^pos stem cells provides multipotent dendritic cell (DC) precursors for tumor-DC hybridization and active immunization

Ex vivo potentiation of anti-tumor T-cell therapeutic efficacy reflects early enhancements in trafficking, decreased apoptotic susceptibility, and diminished granzyme/perforin expression

Active immunotherapy of advanced intracranial tumors through intrasplenic vaccination with DC-tumor electrofusion heterokaryons

Nonmyeloablative radiation enables successful anti-tumor adoptive immunotherapy by an abscopal (remote) mechanism associated with activation and mobilization of CD34(pos) stem cells.

Adoptive immunotherapy with polyclonal tumor-reactive CD8 T cells hyperexpanded to greater than 10⁸-fold.

In vitro correlates of anti-tumor T cell adoptive therapy: Culture conditions can dictate therapeutic outcome and T cell apoptotic susceptibility independent of detectable repertoire shifts

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only